Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × binimetinib × Thoracic × Clear all

Phase

Status

Completed 8 Terminated 5 Active not recruiting 3 Withdrawn 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4 Thoracic 1

Conditions

Recurrence 1 Lung Neoplasms 1

Interventions

Cisplatin 125 Carboplatin 122 Pemetrexed 98 Docetaxel 72 Erlotinib Hydrochloride 55 Gefitinib 51 Gemcitabine 50 Drug Therapy 47 Paclitaxel 45 anlotinib 44 Radiotherapy 44 Bevacizumab 44 Etoposide 41 icotinib 38 apatinib 38 pembrolizumab 35 camrelizumab 34 osimertinib 33 Nivolumab 30 Vinorelbine 29 durvalumab 25 sintilimab 22 Radiosurgery 22 endostar protein 21 Endostatins 21 aumolertinib 20 atezolizumab 20 Blood Specimen Collection 19 toripalimab 17 Irinotecan 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04292119 2021-03-10

Lorlatinib Combinations in Lung Cancer

Massachusetts General Hospital

Phase 1/2 Unknown

Lung Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡